Natalia N. Mitina, Elena Vladimirovna Kondakova, Victor S. Tarabykin, Aleksey A. Babaev
{"title":"ANIMAL MODELS OF EPILEPSY","authors":"Natalia N. Mitina, Elena Vladimirovna Kondakova, Victor S. Tarabykin, Aleksey A. Babaev","doi":"10.23868/gc568026","DOIUrl":null,"url":null,"abstract":"Animal models of epilepsy are valuable tools for studying the pathogenesis of the disease, developing new methods of treatment, searching for anticonvulsants and evaluating their effectiveness. Rodents, such as rats and mice, are the most popular subjects for research due to the similarity of the human and rodent brain structure. Recent studies include other model species such as dogs, cats, primates, as well as non-mammals such as zebrafish, fruit flies, leeches and planarians. This article discusses the use of animal models in research and analyzes their advantages and limitations. The classification of models is based on the phenotype of the disorder , with special attention paid to drug-resistant epilepsy. The article also highlights the imperfection of existing models and the need to select the most relevant for specific research purposes. It is also important to remember that animal models cannot fully recreate the complexity of the clinical picture of epilepsy in humans, but they play an important role in understanding the mechanisms of the disease and developing new therapeutic approaches.
 In conclusion, the article highlights the need for continuous improvement of existing animal models and the development of new ones to more accurately reflect the diversity of epilepsy phenotypes and provide more effective research and treatment methods. The need for new models of drug-resistant epilepsy, which could help in the development of fundamentally new antiepileptic drugs, remains particularly relevant.","PeriodicalId":12644,"journal":{"name":"Genes and Cells","volume":"20 9","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genes and Cells","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23868/gc568026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Animal models of epilepsy are valuable tools for studying the pathogenesis of the disease, developing new methods of treatment, searching for anticonvulsants and evaluating their effectiveness. Rodents, such as rats and mice, are the most popular subjects for research due to the similarity of the human and rodent brain structure. Recent studies include other model species such as dogs, cats, primates, as well as non-mammals such as zebrafish, fruit flies, leeches and planarians. This article discusses the use of animal models in research and analyzes their advantages and limitations. The classification of models is based on the phenotype of the disorder , with special attention paid to drug-resistant epilepsy. The article also highlights the imperfection of existing models and the need to select the most relevant for specific research purposes. It is also important to remember that animal models cannot fully recreate the complexity of the clinical picture of epilepsy in humans, but they play an important role in understanding the mechanisms of the disease and developing new therapeutic approaches.
In conclusion, the article highlights the need for continuous improvement of existing animal models and the development of new ones to more accurately reflect the diversity of epilepsy phenotypes and provide more effective research and treatment methods. The need for new models of drug-resistant epilepsy, which could help in the development of fundamentally new antiepileptic drugs, remains particularly relevant.
期刊介绍:
“Genes and Cells” (the old name is “Cell Transplantology and Tissue Engineering”) is a peer-reviewed scientific and practical journal recommended by the Higher Attestation Commission of the Ministry of Education and Science of the Russian Federation for publishing basic materials of dissertation research. Originally conceived as a highly specialized publication, the Journal has now gained an ever wider target audience. If at the beginning of its journey — from September 2005 — the target audience of the journal were biotechnologists, specialists in the field of molecular and cell biology, by now it has expanded with medical practitioners. Such progressive dynamics are absolutely natural — over the last 7-10 years, biomedical technologies have come out of the exotic category, lack of understanding of the inhabitants and mistrust of clinicians have been replaced by interest and awareness of the need to use biotechnology tools in medicine no longer tomorrow, but today. The sections of the journal are formulated to fully disclose the target topics of the publication, convey to readers the opinions of leading experts in the field of biomedical technologies on topical issues of concern, acquaint them with the most significant recent foreign and domestic research, materials of thematic conferences, present analytical information on fundamental issues of biomedical technologies trends in the biotech business. The journal includes the following headings: “expert opinions”, “cell technology news”, “reviews”, “original research”, “clinical experience”, “discussion and general theoretical work”, “stem cell business”.